
PENNINGTONS MANCHES COOPERS CORPORATE TEAM ADVISES ON MAJOR CROSS-BORDER LIFE SCIENCES TRANSACTION
The Penningtons Manches Cooper corporate team has advised the shareholders of ATDBio on its sale to NASDAQ Stockholm listed Biotage AB. The purchase price was approximately £45m on a debt free and cash free basis. ATDBio was founded in 2005 by Professor Tom Brown (Snr), one of the world’s leading nucleic acids chemists, Dr Dorcas […]
The Penningtons Manches Cooper corporate team has advised the shareholders of ATDBio on its sale to NASDAQ Stockholm listed Biotage AB. The purchase price was approximately £45m on a debt free and cash free basis.
ATDBio was founded in 2005 by Professor Tom Brown (Snr), one of the world’s leading nucleic acids chemists, Dr Dorcas Brown, an expert in oligonucleotide synthesis, Dr Tom Brown (Jnr) and Dr Asha Brown. The company has laboratories in Oxford and Southampton and works with its customers to develop simple, rapid and accurate human diagnostic methods. In 2020 it expanded to meet the demands of the pandemic response – increasing its synthesis capacity by more than ten times to make oligonucleotides for millions of COVID-19 tests.
The acquisition, which provides Biotage with expertise in highly complex DNA and RNA production, will allow accelerated expansion of the UK company’s activities. ATDBio’s founders are joining the Biotage Group as part of the acquisition, continuing to work with existing and new customers on molecular diagnostics, nucleic acid-based therapeutics and vaccines plus new generation DNA and RNA sequencing technologies.
The deal was led by Oxford corporate partner Will Axtell with support predominantly from Giordano Suergiu (corporate), Kathy Hills (tax), Leonie Langley (tax), Luke Shaw (employment), Chris Shelley (IP), Clare Coley (pensions) and Giorgia Clements (property). Biotage AB were advised by Herbert Smith Freehills.
Dr Tom Brown Jr, Director of ATDBio said of the transaction, “ATDBio is very proud to be joining the Biotage Group. With its global presence and world-leading separation science expertise, and our leadership in complex oligonucleotide synthesis, our businesses are highly complementary. With this exciting merger we look forward to scaling up our activities with existing and new customers.
Will and the rest of the Penningtons team were a reassuring presence guiding us through the process and we particularly valued their combined M&A expertise and life sciences sector knowledge.”
More in Tech, IT & Comms

Tracker calls time on tech-savvy car thieves
NEWS RELEASE FOR IMMEDIATE RELEASE Tracker calls time on tech-savvy car thieves Keyless car theft at an all-time high, prompting plans to clampdown on the sale of hacking technology LONDON, 18th July 2022 – Stolen vehicle recovery (SVR) expert Tracker Network UK Limited, is urging motorists to be extra vigilant as the number of car […]

Penningtons Manches Cooper seek Cyber Security Firm of the Year
We’re delighted to sponsor the Cyber Security Firm of the Year category at The Business Magazine’s Thames Valley Tech Awards.

‘World Productivity Day: ‘Conker celebrates World Productivity Day and offers its...
Productivity is defined as “the efficiency and quality of production of goods or services” in transport and logistics this could mean ton-miles per vehicle or daily deliveries per driver. Some barriers to productivity include distraction and interruptions, lack of information, ineffective communication, insufficient training, inadequate tools and equipment, stress and too much to do. […]
From this author

Penningtons Manches Cooper teams recognised in IAM Patent 1000
It’s great to see our IP, IT and commercial team recognised in the latest IAM Patent 1000. The firm is recommended in the transactions category, while four individual lawyers – Rachel Bradley, Lisa Page, Chris Shelley and Dr Duncan Curley – are also recognised. Rachel, Lisa and Chris are recommended for transactions, and Duncan for […]

Penningtons Manches Cooper advises Titian Software on majority investment from Battery...
The corporate team at Penningtons Manches Cooper has advised shareholders of Titian Software, a leading sample management software solution provider to the life sciences sector, on the significant, majority investment from Battery Ventures, a US technology-focused investment firm.

Penningtons Manches Cooper seek Cyber Security Firm of the Year
We’re delighted to sponsor the Cyber Security Firm of the Year category at The Business Magazine’s Thames Valley Tech Awards.